Anticoagulation is a critical component in the treatment of cardiovascular diseases. Large randomised controlled trials have ...

The anticoagulant medication dabigatran yielded similar results to warfarin for the prevention of cognitive decline in older adults with atrial fibrillation after two years of treatment, according to ...

NEW ORLEANS — A therapeutic vs. prophylactic dose of anticoagulation therapy did not significantly improve outcomes for noncritically ill patients hospitalized with COVID-19, though fewer therapeutic ...

HELSINKI, Finland — The pros and cons of early vs late initiation of a direct oral anticoagulant (OAC) after acute ischemic stroke in the setting of atrial fibrillation (AF) for secondary prevention ...

"Cadrenal Therapeutics has demonstrated a commitment to filling a serious gap in anticoagulation therapy," said Lisa Winget, Managing Editor at Pharma Tech Outlook. "We are pleased to recognize ...

Data from more than 13,000 patients with AF show that the use of edoxaban over four years is associated with a low annualised rate of all-cause death, ischaemic stroke and major bleeding. 1, 2 The ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it expanded its Phase III OCEANIC clinical development program for the investigational drug asundexian (BAY2433334) by initiating a third ...

New observational data showed no significant difference in subsequent ischemic stroke with anticoagulation compared with antiplatelet therapy, although there was a nonsignificant trend toward a lower ...

The treatment of atrial fibrillation (AF) takes a 2-pronged approach that addresses (1) symptoms caused by the arrhythmia and (2) safety, which is largely focused on reduction of the risk of stroke ...

This multicenter retrospective cohort study included adult patients with cancer diagnosed with venous thromboembolism (VTE) hospitalized in Thailand from 2017 to 2021. Anticoagulants were classified ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Recognized as innovative biopharma developing a potentially safer and superior anticoagulant for patients with implanted cardiac devices and rare cardiovascular conditions PONTE VEDRA, Fla., Nov. 19, ...